Immune response to influenza vaccination in institutionalized elderly: Effect on different T-cell subsets

Vaccine

Volumn 16, Issue 4, 1998, Pages 403-409

  McElhaney, Janet E ^a,d   Gravenstein, Stefan ^b   Upshaw, Craig M ^a   Hooton, Jonathan W ^a   Krause, Peggy ^c   Drinka, Paul ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Wisconsin Department of Veterans Affairs   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cell mediated immunity; Cytokines; Elderly; Granzyme B; Influenza vaccination; T cell subsets

Indexed keywords

GRANZYME B; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 2;

AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032008114     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)80918-8     Document Type: Article

References (43)

1. 1 Howells, C.H.L., Vesselinove-Jenkins, C.K., Evans, A.D. and James, J. Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet 1975, 1, 381-383.
2. 2 Brandiss, M.W., Betts, R.F., Mathur, U. and Douglas, R.G. Responses of elderly subjects to monovalent A/USSR/ 77(H1N1) and trivalent A/USSR/77 (H1N1), Texas/77 (H3N2), B/Hong Kong/72 vaccines. Am. Rev. Respir. Dis. 1981, 124, 681-684.
3. 3 Gravenstein, S., Miller, B.A., Duthie, E.A. et al. , Barker, W.H. and Mullooly, J.P. Enhancement of anti-influenza antibody response in elderly men by thymosin alpha one. Clin. Res. 1987, 35, 346a.
4. 4 Barker, W.H. and Mullooly, J.P. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and details. J. Am. Med. Assoc. 1980, 244, 2547-2549.
5. 5 Powers, D.C. Influenza vaccination strategies in the elderly. Aging Immunol. Infect. Dis. 1994, 5, 47-54.
6. 6 Powers, D.C. and Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis. 1993, 167, 584-592.
7. 7 D'Alessio, D.J., Cox, P.M. Jr and Dick, E.G. Failure of activated influenza vaccine to protect an aged population. J. Am. Med. Assoc. 1969, 210, 485-489.
8. 8 Ferry, B.J., Evered, M.G. and Morrison, E.I. Different protection rates in various groups of volunteers given subunit influenza vaccine in 1976. J. Infect. Dis. 1979, 39, 237-241.
9. 9 Hobson, D.D., Curry, R.L., Beare, A.S. and Gardner, A. The role of serum hemagglutination-inhibiting antibody in protection against challenger infection with influenza A2 and B virus. J. Hyg. 1972, 70, 767-777.
10. 10 Govaert, T.M.E., Sprenger, M.J.W., Dinant, G.J., Aretz, K., Masurel, N. and Knottnerus, J.A. Immune response to influenza vaccination in elderly people - a randomized double-blind placebo-controlled trial. Vaccine 1994, 12, 1185-1189.
11. 11 Yap, K.L., Ada, G.L. and McKenzie, F.C. Transfer of specific cytotoxic T lymphocytes protects mice innoculated with live influenza virus. Nature 1978, 273, 238-239.
12. 12 Yap, K.L. and Ada, G.L. Cytotoxic T cells in the lungs of mice infected with influenza A virus. Scand. J. Immunol. 1978, 7, 73-80.
13. 13 Taylor, P.M. and Askonas, B.A. Influenza nucleoprotein specific cytotoxic T cell clones are protective in vivo. Immunology 1986, 58, 417-420.
14. 14 Bender, B.S., Crogham, T., Zhang, L. and Small, P.A. Jr Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 1992, 175, 1143-1145.
15. + T cell clones vary in function in vitro and in influenza infection in vivo. Int. Immunol. 1990, 2, 323-328.
16. + T cells. J. Immunol. 1990, 144, 3980-3986.
17. 17 Scherle, P.A., Palladino, G. and Gerhard, W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 1992, 148, 212-217.
18. 18 Biddison, W.E., Sharrow, S.O. and Shearer, G.M. T cell subpopulations required for the human cytotoxic T lymphocyte response to influenza virus: evidence for T cell help. J. Immunol. 1981, 127, 487-491.
19. + T cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro. J. Virol. 1991, 65, 6071-6076.
20. h2 cells: different patterns of lymphokine secretion lead to different functional properties. A Rev. Immunol. 1989, 7, 145-173.
21. 21 Ramsay, A.J., Ruby, J. and Ramshaw, I.A. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 1993, 14, 155-157.
22. 22 Poe, M., Blake, J.T. and Boulton, D.A. et al. Human cytotoxic lymphocyte granzyme B - its purification from granules and the characterization of substrate and inhibitor specificity. J. Biol. Chem. 1991, 266, 98-103.
23. 23 Prendergast, J.A., Helgason, C.D. and Bleackley, R.C. Quantitative polymerase chain reaction analysis of cytotoxic cell proteinase gene transcripts in T cells - pattern of expression is dependent on the nature of the stimulus. J. Biol. Chem. 1972, 267, 5090-5095.
24. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 1994, 180, 1273-1282.
25. 25 Russell, S.M. and Liew, F.Y. T cells primed by influenza virion internal components can cooperate in the antibody response to hemagglutinin. Nature 1987, 280, 147-148.
26. 26 Butchko, G.M., Armstrong, R.B. and Ennis, F.A. Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses. J. Immunol. 1978, 121, 2381-2385.
27. 27 Effros, R.B., Doherty, P.C., Gerhard, W. and Bennink, J. Generation of both cross-reactive and virus specific T cell populations after immunization with serologically distinct influenza A viruses. J. Exp. Med. 1977, 145, 557-566.
28. 28 Fischer, A., Nash, S., Beverley, P.C.L. and Feldmann, M. An influenza virus matrix protein-specific human T cell line with helper activity for in vitro anti-hemagglutinin antibody production. Eur. J. Immunol. 1982, 12, 844-899.
29. 29 WHO Collaborating Center for Influenza, Biological Products Division. The Hemagglutination Inhibition Test for Influenza Viruses. Verson 31 revised, DHEW, PHS, CDC, Center for Infectious Disease, Atlanta, GA, USA, 1981, pp. 1-21
30. 30 McElhaney, J.E., Meneilly, G.S., Lechelt, K.E., Bleackley, R.C., Hooton, J.W.L., Gibbs, C. and Paetkau, V. Split-virus influenza vaccines: do they provide adequate immunity in the elderly?. J. Gerontol. 1994, 49, M37-43.
31. 31 Hooton, J.W.L., Gibbs, C. and Paetkau, V. Interaction of interleukin 2 with cells: quantitative analysis of effects. J. Immunol. 1985, 135, 2464-2473.
32. 32 McElhaney, J.E., Pinkoski, M.J., Au, D., Lechelt, K.E., Bleackley, R.C. and Meneilly, G.S. Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly. Vaccine 1996, 14, 539-544.
33. 33 McElhaney, J.E., Pinkoski, M.J., Upshaw, C. and Bleackley, R.C. The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity. J. Immunol. Meth. 1996, 190, 11-26.
34. 34 Ahmed, A.E.H., Nicholson, K.G. and Nguyen-Van-Tam, J.S. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995, 346, 591-595.
35. 35 Glathe, H., Bigl, S. and Grosche, A. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. Vaccine 1993, 11, 702-705.
36. 36 Garenne, M., Leory, O., Beau, J-P. and Sene, I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 1991, 338, 903-907.
37. 37 Brockman-Schneider, R.A., Schilling, M.L., Schmitt, F.R. et al. 2-year comparison of antibody response to influenza vaccination in elderly nursing home residents. Submitted for publication
38. 38 Hussey, G.D., Goddard, E.A. and Hughes, J. et al. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune responses in infants. J. Infect. Dis. 1996, 173, 1320-1326.
39. h2 response. Clin. Immunol. Immunopath. 1993, 67, 171-177.
40. 40 Gorse, G.J. and Belshe, R.B. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill patients. J. Clin. Microbiol. 1990, 28, 2539-2550.
41. 41 Powers, D.C. and Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis. 1993, 167, 584-592.
42. 42 McElhaney, J.E., Pinkoski, M.J., Au, D., Lechelt, K.E., Bleackley, B.C. and Meneilly, G.S. Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly. Vaccine 1996, 14, 539-544.
43. 43 McElhaney, J.E., Beattie, B.L., Devine, R., Grynoch, R., Toth, E.L. and Bleackley, R.C. Age-related decline in interleukin-2 production in response to influenza vaccine. Journal of American Geriatric Society 1990, 38, 652-658.